WOW, their SP jumps by 135% on this ann.. Shouldn’t our SP go up as well . hahahaThe market is really hard to understand sometimes..
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%